Unlock the next level of innovation in ocular drug development with Pharmaron’s comprehensive expertise in ocular efficacy and PK and toxicology studies. Whether advancing small molecules, biologics, or cell and gene therapies, Pharmaron delivers robust support from preclinical evaluation to clinical translation.

With over a decade of specialized experience, our team of ocular scientists and board-certified veterinary ophthalmologists utilize cutting-edge tools and techniques to assess critical endpoints. From state-of-the-art imaging systems like OCT and fundus photography to custom disease models for glaucoma, diabetic retinopathy, and inherited retinal disorders, our resources ensure precision in every study.

Key takeaways from this brochure include:

• Extensive experience in ocular biodistribution, offering insights into drug delivery via specialized routes like intravitreal and sub-retinal injections.
• Advanced tools for anterior and posterior chamber evaluations include pachymetry, tonometry, and multifocal electroretinograms.
• Rigorous compliance with regulatory standards, ensuring quality and reliability at every step.

Pharmaron’s expertise bridges the gap between discovery and clinical application, accelerating your path to regulatory approval. Download the brochure today to learn how our tailored services can enhance research outcomes.